Keralam Assembly: Orders issued to procure 2,159 bottles of SMA drug, says Health Minister

The health ministry of Kerala has issued an order to procure 2,159 bottles of a specialized medication for spinal muscular atrophy, a genetic disorder that weakens muscles and can be fatal in early childhood. The decision was communicated during a legislative session where the minister responded to a written submission from a concerned citizen group. By securing a large quantity of the drug, the government hopes to eliminate shortages that have previously forced families to seek treatment outside the state.

Spinal muscular atrophy affects a small number of children but carries a high burden for families because of the cost and limited availability of therapy. Under the Kerala United Against Rare Diseases scheme, the state has been building a network of diagnostic centers, counseling services, and financial assistance programs. The new procurement will be distributed through government hospitals and approved private clinics, ensuring that children diagnosed with SMA can start treatment without delay. The scheme also includes training for pediatric neurologists to improve early detection, which is essential for better outcomes.

The announcement has been welcomed by patient advocacy groups, who say the move demonstrates the government's commitment to rare disease care. It also aligns with national efforts to improve access to high‑cost medicines through price negotiations and insurance coverage. Observers note that the procurement could set a precedent for other states to follow, potentially creating a larger market that drives down prices. The health minister emphasized that the state will continue to monitor supply chains and adjust orders as needed to meet demand.